Treatment of Parkinson's disease with levodopa and Ro 4-4602

Clin Pharmacol Ther. 1971 Mar-Apr;12(2):353-9. doi: 10.1002/cpt1971122part2353.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Clinical Trials as Topic
  • Dihydroxyphenylalanine / administration & dosage
  • Dihydroxyphenylalanine / adverse effects
  • Dihydroxyphenylalanine / therapeutic use*
  • Female
  • Humans
  • Hydrazines / administration & dosage
  • Hydrazines / adverse effects
  • Hydrazines / therapeutic use*
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy*

Substances

  • Hydrazines
  • Dihydroxyphenylalanine